manufacturer informed commission of the sales view to initiating infringement against the commission claims that there was insufficient proof the inhalers satisfied the requirements in the directive and i c
The manufacturer informed the Commission of the second sales prohibition with a view to initiating infringement proceedings against Germany, but the Commission claims that there was insufficient proof that the inhaler satisfied the essential requirements stipulated in the directive, and it concluded that there was no need for a new product safety review.
The manufacturer informed Commission of the sales view to initiating infringement against the Commission claims that there was insufficient proof the inhaler satisfied the requirements in the directive, and it concluded that there was no need a new product safety review.